Are the PCSK9 Inhibitors the Panacea of Atherosclerosis Treatment: Effects on Lipid Lowering and Beyond - Evan Stein, MD, PhD

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Are the PCSK9 Inhibitors the Panacea of Atherosclerosis Treatment: Effects on Lipid Lowering and Beyond presented by Evan Stein, MD, PhD at CRT 2016

Loading Simple Education